In Regard to Allen et al.: Fatal Pneumonitis Associated With Intensity-Modulated Radiation Therapy for Mesothelioma (Int J Radiat Oncol Biol Phys 2006;65:640-645)

International Journal of Radiation Oncology Biology Physics

Volumn 68, Issue 3, 2007, Pages 959-

  Rodrigues, George B ^a,b   Roa, Wilson H ^a,b  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b CROSS CANCER INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER RADIOTHERAPY; FATALITY; HUMAN; INTENSITY MODULATED RADIATION THERAPY; LETTER; LUNG NON SMALL CELL CANCER; MESOTHELIOMA; PNEUMONIA; PRIORITY JOURNAL; RADIATION DOSE; RADIATION HAZARD;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; CISPLATIN; FEMALE; GLUTAMATES; GUANINE; HUMANS; MALE; MESOTHELIOMA; MIDDLE AGED; PNEUMONECTOMY; RADIATION PNEUMONITIS; RADIOTHERAPY, ADJUVANT; RADIOTHERAPY, INTENSITY-MODULATED; RESPIRATORY INSUFFICIENCY; RETROSPECTIVE STUDIES;

EID: 34249311309     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2007.02.013     Document Type: Letter

References (9)

1. Allen A.M., Czerminska M., Jänne P.A., et al. Fatal pneumonitis associated with intensity-modulated radiation therapy for mesothelioma. Int J Radiat Oncol Biol Phys 65 (2006) 640-645
2. Holloway C.L., Robinson D., Murray B., et al. Results of a phase I study to dose escalate using intensity modulated radiotherapy guided by combined PET/CT imaging with induction chemotherapy for patients with non-small cell lung cancer. Radiother Oncol 73 (1997) 285-287
3. Armstrong J., Raben A., Zelefsky M., et al. Promising survival with three-dimensional conformal radiation therapy for non-small cell lung cancer. Radiother Oncol 44 (1997) 17-22
4. Graham M.V., Purdy J.A., Emami B., et al. Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC). Int J Radiat Oncol Biol Phys 45 (1999) 323-329
5. Tsujino K., Hirota S., Endo M., et al. Predictive value of dose-volume histogram parameters for predicting radiation pneumonitis after concurrent chemoradiation for lung cancer. Int J Radiat Oncol Biol Phys 55 (2003) 110-115
6. Hope A.J., Lindsay P.E., Naqa I.E., et al. Modeling radiation pneumonitis risk with clinical, dosimetric, and spatial parameters. Int J Radiat Oncol Biol Phys 65 (2006) 112-124
7. Chen Y., Hyrien O., Williams J., et al. Interleukin (IL)-1A and IL-6: Applications to predictive diagnostic testing of radiation pneumonitis. Int J Radiat Oncol Biol Phys 62 (2005) 260-266
8. Murshed H., Liu H.H., Liao Z., et al. Dose and volume reduction for normal lung using intensity-modulated radiotherapy for advanced-stage non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 58 (2004) 1258-1267
9. Liu H.H., Wang X., Dong L., et al. Feasibility of sparing lung and other thoracic structures with intensity-modulated radiotherapy for non-small cell lung cancer. Int J Radiat Oncol Biol Phys 58 (2004) 1268-1279